Crystalys Therapeutics Welcomes Former Horizon CEO Tim Walbert as Independent Director to Drive Gout Treatment Innovations Crystalys Therapeutics has appointed Tim Walbert, former CEO of Horizon Therapeutics, as an Independent Director, enhancing its leadership in gout treatments.

Crystalys Therapeutics Welcomes Former Horizon CEO Tim Walbert as Independent Director to Drive Gout Treatment Innovations #United_States #San_Diego #Gout_Treatment #Crystalys_Therapeutics #Tim_Walbert